S. 2192, A bill to establish a user fee for follow-up reinspections under the Federal Food, Drug, and Cosmetic Act

• This item is from the 110th Congress (2007-2008) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.

Version saved on March 14, 2008, 04:12:39, by webmaster:

S. 2192 would establish a user fee for follow-up reinspections under the Federal Food, Drug, and Cosmetic Act.

Detailed Summary

Directs the Secretary of Health and Human Services to collect a user fee from each manufacturer of a food, drug, device, biological product, or animal drug for which a followup reinspection is required to ensure correction of a violation of a Good Manufacturing Practices requirement under the Federal Food, Drug, and Cosmetic Act found by the Secretary during the initial inspection of the manufacturer.

Status of the Legislation

Latest Major Action: 10/18/2007: Referred to Senate committee. Status: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Points in Favor

(Log in to edit the wiki and be the first to show why the bill should pass!)

Points Against

(Log in to edit the wiki and be the first to show why the bill should not pass!)

« Return to Revision History.